Latest Announcements

Glenmark Pharmaceuticals Limited has informed the Exchange regarding 'Investors Presentation' for Q2 FY27, with Consolidated Revenue of Rs. 42,473 million, Like-for-Like YoY growth of ~20% in India, a strong recovery in North America, and robust performance across Emerging Markets.

Zen Technologies Ltd has announced its Q2 and H1 FY2027 earnings, with consolidated revenue from operations for Q2 FY2027 at Rs.345.1 crores, a 98.8% growth over Q2 FY2026, and operational EBITDA margin of 38.2%. The company has guided a full-year operational EBITDA margin in the mid-30s.

Hindalco Industries Ltd's wholly owned subsidiary Novelis Inc. reported Q2 FY27 results with net income attributable to common shareholder up 29% YoY to $210 million, driven by insurance recoveries and higher Adjusted EBITDA.

Hindalco Industries Limited has informed the Exchange about Investor Presentation for Novelis Inc., a wholly owned subsidiary, for its Q2 FY27 results. The presentation includes news release and earnings presentation. Net income attributable to common shareholder grew 29% YoY to $210 million.

Sundram Fasteners Ltd reported a 30% growth in revenues for Q2 FY27, driven by the OE segment, and a 57% growth in exports, with a 25% growth in exports as a percentage of total revenues. The company has offset the impact of raw material cost inflation through pass-through arrangements and operating leverage.

India Shelter Finance Corporation Limited has released its unaudited financial results for Q2FY27, showing a 23% YoY growth in Gross AUM to Rs. 11,997 Crs, and a 19% YoY growth in PAT to Rs. 146 Crs.

iValue Infosolutions Ltd reported Q2FY27 results, with gross sales of ₹731.6 crore, up 14.1% QoQ, and PAT increased 48.7% QoQ. Annuity Business stood at ₹437.0 crore, registering a growth of 47.0% QoQ. Operating EBITDA stood at ₹31.3 crore, an increase of 54.7% QoQ with margin of 4.3% on gross sales and 16.3% on net basis.

Muthoot Microfin Ltd announced its unaudited financial performance for Q2 FY27, with highest-ever quarterly disbursements of Rs. 2,900 crore, and a 22% YoY growth in Gross Loan Portfolio (GLP) to Rs. 15,323 crore. The company's Net Interest Margin (NIM) improved by 50 bps QoQ to 12.5%, and Profit After Tax (PAT) stood at Rs. 110.8 crore, registering a growth of 262.9% YoY.

Muthoot Microfin Limited announced its unaudited financial performance for the quarter and half year of the financial year 2026-27, with a strong business momentum and a diversified and resilient enterprise for the future. The company achieved the highest-ever quarterly disbursements of Rs. 2,900 crore, with a growth of 27.5% YoY and 9.7% QoQ. Gross Loan Portfolio (GLP) reached Rs.15,323 crore, registering a growth of 22.0% YoY. Non-JLG portfolio increased to 31% of GLP, reflecting the company's progress in diversifying its portfolio beyond the traditional JLG segment.

Glenmark Pharmaceuticals Ltd announced its Q2 FY27 results, with consolidated revenue of Rs. 42,473 million, a 20% YoY growth on a like-for-like basis. EBITDA was Rs. 8,638 million, with an EBITDA margin of 20.3%. Adjusted PAT was Rs. 4,852 million, with an adjusted PAT margin of 11.4%. The company reported a strong recovery in North America, supported by multiple launches, and robust performance across Emerging Markets.

Hindalco Industries Ltd's wholly owned subsidiary Novelis Inc. has published its Q2 FY27 results, with net income attributable to common shareholders growing 29% YoY to $210 million. Net sales increased 25% to $5.9 billion, driven by higher average aluminum prices. Adjusted EBITDA rose 20% to $508 million, with insurance recoveries and favorable metal benefits contributing to the improvement.

Glenmark Pharmaceuticals Limited has announced its Q2 FY27 results, with consolidated revenue growing approximately 20% YoY to Rs. 42,473 million. The company reported EBITDA of Rs. 8,638 million and Adjusted Profit After Tax (PAT) of Rs. 4,852 million. The management expressed confidence in delivering FY27 guidance with continued growth in India, a strong recovery in North America, and robust performance across Emerging Markets.

Ajmera Realty & Infra India Limited held an earnings conference call for Q2 and H1 FY27, discussing the real estate sector's resilience and growth opportunities, particularly in premium and lifestyle-oriented housing. The company's CFO presented financial numbers, and the Director of Corporate Affairs highlighted the sector's positive response in major cities and the demand for commercial assets.

Hindalco's subsidiary Novelis reports Q2 FY27 results, with net income attributable to common shareholder up 29% YoY, and Adjusted EBITDA up 20% YoY. Net cash used in operating activities was an outflow of $418 million, and Adjusted free cash flow was an outflow of $1.8 billion.

Aditya Vision Ltd reported its best-ever Q2 performance with revenue growing 28% YoY to Rs. 586 crores, driven by the resilience of its business model and customer franchise. Despite headwinds impacting discretionary spending, the company demonstrated resilience and delivered a strong performance, with EBITDA growing by 32% and PAT growing by 45% in Q2 FY 2027. The company's expansion strategy combines deeper penetration in existing markets with entry into new geographies, with a retail footprint expanding by 18.3% to approximately 9.51 lakh square feet.

iValue Infosolutions Limited has reported its Q2FY27 results, with gross sales increasing 14.1% QoQ to ₹731.6 crore, and PAT growing 48.7% QoQ to ₹23.4 crore.

Hi-Tech Pipes Limited has informed the Exchange about Investor Presentation for Q2&H1FY27, showcasing strong revenue and EBITDA growth, with a +70.74% and +27.63% YoY increase respectively. The company has also highlighted its key performance indicators, including sales volume and EBITDA per MT.

Hi-Tech Pipes Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, showing a 70.74% year-on-year increase in revenue and a 27.63% year-on-year increase in EBITDA.

Artemis Medicare Services Limited has informed the Exchange about Transcript of Earnings Conference Call - Q2 and H1 FY27. The company's consolidated revenue from operations for Q2 FY27 was INR 311 crores, representing year-on-year growth of 13.2%. Profit after tax for the quarter was INR 31 crore, representing a year-on-year growth of 3.7%. The company's focus remains on better utilization of clinical capacity, managing operational costs, and improving the contribution from specialized procedures.

Aditya Vision Limited has informed the Exchange about Transcript of Analysts/Investors Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2026. The company delivered its best-ever Q2 performance, with revenue growing 28% year-on-year to Rs. 586 crores and EBITDA growing by 32%.